Moxifloxacin Supplier-Buyer Network — Trade Flow Analysis

Name: Moxifloxacin Supplier-Buyer Trade Network Dataset — 336+ Indian Exporters, 23+ Importers, 137+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Moxifloxacin supplier network, Moxifloxacin buyers, pharmaceutical export India, Moxifloxacin trade data

TransData Nexus

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Who Supplies Moxifloxacin? Top Manufacturers & Buyers 2026 — MACLEODS PHARMACEUTICALS LTD Leads | TransData Nexus | TransData Nexus

1MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the first-largest Moxifloxacin exporter from India, with a market share of 43.7% and a total export value of $14.3M across 27 shipments. Their average shipment value of $531.3K is above the market average of $13.6K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. NATIONAL TUBERCULOSIS AND LEPROSY is the dominant customer, accounting for 96.4% of this supplier's tracked business. Top customers include:

• NATIONAL TUBERCULOSIS AND LEPROSY — $13.8M across 26 shipments (96.4% of this supplier's total exports)

• I+ SOLUTIONS, — $199.8K across 0 shipments (1.4% of this supplier's total exports)

• DEPARTMENT OF HEALTH — $191.6K across 0 shipments (1.3% of this supplier's total exports)

• BRANCH CO MACLEODS P — $83.6K across 0 shipments (0.6% of this supplier's total exports)

• MACLEODS PHARMACEUTI — $34.3K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $531.3K is 3807% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.

2MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED is the second-largest Moxifloxacin exporter from India, with a market share of 4.8% and a total export value of $1.6M across 89 shipments. Their average shipment value of $17.7K is above the market average of $13.6K, suggesting premium or bulk contract pricing.

MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• I+ SOLUTIONS, — $485.2K across 27 shipments (30.7% of this supplier's total exports)

• TO THE ORDER OF — $466.4K across 26 shipments (29.5% of this supplier's total exports)

• NOVADOZ PHARMACEUTICALS LLC — $249.6K across 14 shipments (15.8% of this supplier's total exports)

• I+ SOLUTIONS, — $245.9K across 14 shipments (15.6% of this supplier's total exports)

• I SOLUTIONS POLARNER — $132.0K across 7 shipments (8.4% of this supplier's total exports)

Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $17.7K is 30% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.

3EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the third-largest Moxifloxacin exporter from India, with a market share of 3.9% and a total export value of $1.3M across 39 shipments. Their average shipment value of $32.9K is above the market average of $13.6K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• NORTHSTAR DISTRIBUTION CENTER 8912 — $511.0K across 16 shipments (39.9% of this supplier's total exports)

• AUROBINDO PHARMA USA., INC, — $442.3K across 13 shipments (34.5% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $125.7K across 4 shipments (9.8% of this supplier's total exports)

• AUROBINDO PHARMA USA., INC, — $107.3K across 3 shipments (8.4% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $94.9K across 3 shipments (7.4% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $32.9K is 142% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.

4MICRO LABS LIMITED

MICRO LABS LIMITED is the fourth-largest Moxifloxacin exporter from India, with a market share of 3.2% and a total export value of $1.1M across 86 shipments. Their average shipment value of $12.3K is below the market average of $13.6K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MICRO NOVA PHARMACEUTICALS IND — $282.7K across 23 shipments (26.7% of this supplier's total exports)

• MAXIM INTER-CORPORATION LTD. — $215.1K across 17 shipments (20.3% of this supplier's total exports)

• MSK PHARMALOGISTIC G — $214.7K across 17 shipments (20.3% of this supplier's total exports)

• MAXIM INTER-CORPORATION LTD. — $186.1K across 15 shipments (17.6% of this supplier's total exports)

• MICROSYNERGY PHARMAC — $160.4K across 13 shipments (15.2% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (86 shipments) at a per-shipment value of $12.3K, indicating a broad distribution network with many smaller, regular orders.

5MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fifth-largest Moxifloxacin exporter from India, with a market share of 2.9% and a total export value of $960.4K across 28 shipments. Their average shipment value of $34.3K is above the market average of $13.6K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN INSTITUTIONAL INC 2898 is the dominant customer, accounting for 77.3% of this supplier's tracked business. Top customers include:

• MYLAN INSTITUTIONAL INC 2898 — $742.1K across 22 shipments (77.3% of this supplier's total exports)

• CSP VIATRIS SANTE AT — $117.1K across 3 shipments (12.2% of this supplier's total exports)

• M/S..MYLAN INSTITUTI — $44.7K across 1 shipments (4.7% of this supplier's total exports)

• MYLAN INSTITUTIONAL INC 2898 — $44.6K across 1 shipments (4.6% of this supplier's total exports)

• VIATRIS PHARMACEUTIC — $11.9K across 0 shipments (1.2% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $34.3K is 152% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.

6AJANTA PHARMA LIMITED

AJANTA PHARMA LIMITED is the fifth-largest Moxifloxacin exporter from India, with a market share of 2.7% and a total export value of $899.0K across 112 shipments. Their average shipment value of $8.0K is below the market average of $13.6K, reflecting a high-volume, competitive pricing strategy.

AJANTA PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• PLANET PHARMA SA — $341.8K across 43 shipments (38.0% of this supplier's total exports)

• HAWKARY PHARMACEUITCAL CO.* — $212.7K across 27 shipments (23.7% of this supplier's total exports)

• HARLEYS LIMITED — $123.0K across 15 shipments (13.7% of this supplier's total exports)

• BRANCH OFFICE AJANTA — $119.2K across 15 shipments (13.3% of this supplier's total exports)

• KAWKAB SCIENTIFIC BU — $102.3K across 13 shipments (11.4% of this supplier's total exports)

Key Insight: AJANTA PHARMA LIMITED operates with high shipment frequency (112 shipments) at a per-shipment value of $8.0K, indicating a broad distribution network with many smaller, regular orders.

1Nigeria

Nigeria ranks as the first-largest destination for Moxifloxacin imports from India, with a total trade value of $14.7M across 8 shipments — representing a 44.8% share of all Moxifloxacin exports. The average shipment value of $1.8M is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Moxifloxacin importers in Nigeria: NATIONAL TUBERCULOSIS AND LEPROSY is the largest buyer, accounting for 94.2% ($13.8M) of this market's total imports.

• NATIONAL TUBERCULOSIS AND LEPROSY — $13.8M (94.2% of Nigeria's total)

• MICRO NOVA PHARMACEUTICALS IND — $383.9K (2.6% of Nigeria's total)

Key Insight: Nigeria's per-shipment average of $1.8M (13402% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nigeria is a key market for Moxifloxacin imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Moxifloxacin imports from India, with a total trade value of $5.8M across 82 shipments — representing a 17.5% share of all Moxifloxacin exports. The average shipment value of $70.2K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.

Named Moxifloxacin importers in United States: AUROLOGISTICS LLC, (AUROBINDO PHARM is the largest buyer, accounting for 12.9% ($744.3K) of this market's total imports.

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $744.3K (12.9% of United States's total)

• MYLAN INSTITUTIONAL INC 2898 — $742.1K (12.9% of United States's total)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $569.4K (9.9% of United States's total)

Key Insight: United States's per-shipment average of $70.2K (416% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Moxifloxacin imports from India.

Primary Market

Secondary Market

3Netherlands

Netherlands ranks as the third-largest destination for Moxifloxacin imports from India, with a total trade value of $1.7M across 16 shipments — representing a 5.1% share of all Moxifloxacin exports. The average shipment value of $104.9K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Moxifloxacin importers in Netherlands: I+ SOLUTIONS, is the largest buyer, accounting for 28.9% ($485.2K) of this market's total imports.

• I+ SOLUTIONS, — $485.2K (28.9% of Netherlands's total)

• I+SOLUTIONS — $383.6K (22.9% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $104.9K (671% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Moxifloxacin imports from India.

Primary Market

Secondary Market

4Thailand

Thailand ranks as the fourth-largest destination for Moxifloxacin imports from India, with a total trade value of $1.0M across 12 shipments — representing a 3.2% share of all Moxifloxacin exports. The average shipment value of $86.3K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Moxifloxacin importers in Thailand: MAXIM INTER-CORPORATION LTD is the largest buyer, accounting for 35.4% ($366.4K) of this market's total imports.

• MAXIM INTER-CORPORATION LTD — $366.4K (35.4% of Thailand's total)

• MAXIM INTER-CORPORATION LTD. — $295.5K (28.5% of Thailand's total)

Key Insight: Thailand's per-shipment average of $86.3K (535% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Moxifloxacin imports from India.

Primary Market

Secondary Market

5France

France ranks as the fifth-largest destination for Moxifloxacin imports from India, with a total trade value of $737.5K across 12 shipments — representing a 2.2% share of all Moxifloxacin exports. The average shipment value of $61.5K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Moxifloxacin importers in France: PLANET PHARMA SA is the largest buyer, accounting for 46.3% ($341.8K) of this market's total imports.

• PLANET PHARMA SA — $341.8K (46.3% of France's total)

Key Insight: France's per-shipment average of $61.5K (352% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Moxifloxacin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Moxifloxacin.
2.Flow Mapping: 336 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,413 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 137 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,413 Verified Shipments

336 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

Who Supplies Moxifloxacin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Moxifloxacin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Moxifloxacin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MACLEODS PHARMACEUTICALS LTD

2MSN LABORATORIES PRIVATE LIMITED

3EUGIA PHARMA SPECIALITIES LIMITED

4MICRO LABS LIMITED

5MYLAN LABORATORIES LIMITED

6AJANTA PHARMA LIMITED

From Indian Factories to Global Pharmacies — How Moxifloxacin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Moxifloxacin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Nigeria

2United States

3Netherlands

4Thailand

5France

People Also Ask — Moxifloxacin Supplier & Trade Network

Moxifloxacin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology